These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16203436)

  • 1. Injecting nation: achieving control of hepatitis C in Australia.
    Wodak A
    Drug Alcohol Rev; 1997 Sep; 16(3):275-84. PubMed ID: 16203436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?
    Dolan K; Clement N; Rouen D; Rees V; Shearer J; Wodak A
    Drug Alcohol Rev; 2004 Sep; 23(3):281-6. PubMed ID: 15370007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling and calibration of the hepatitis C epidemic in Australia.
    Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
    Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the hepatitis C virus epidemic in Australia.
    Razali K; Thein HH; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M
    Drug Alcohol Depend; 2007 Dec; 91(2-3):228-35. PubMed ID: 17669601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia.
    Degenhardt L; Black E; Breen C; Bruno R; Kinner S; Roxburgh A; Fry C; Jenkinson R; Ward J; Fetherston J; Weekley J; Fischer J
    Drug Alcohol Rev; 2006 Sep; 25(5):403-12. PubMed ID: 16939934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
    Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
    Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh.
    Sarkar K; Bal B; Mukherjee R; Chakraborty S; Niyogi SK; Saha MK; Bhattacharya SK
    Subst Use Misuse; 2006; 41(3):341-52. PubMed ID: 16467010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
    Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Route transition interventions: potential public health gains from reducing or preventing injecting.
    Bridge J
    Int J Drug Policy; 2010 Mar; 21(2):125-8. PubMed ID: 20167464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nested-epidemic model for the spread of hepatitis C among injecting drug users.
    Esposito N; Rossi C
    Math Biosci; 2004; 188():29-45. PubMed ID: 14766092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Australian study of HIV and injecting Drug Use. Part II: predicting exposure to hepatitis C and hepatitis B.
    Carruthers SJ; Loxley WM; Phillips M; Bevan JS
    Drug Alcohol Rev; 1997 Sep; 16(3):215-20. PubMed ID: 16203430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.